Le Goff Marie, Martino Frédéric, Rossi Geoffrey, Toussaint Aurélia, Moncomble Elsa, Reuter Danielle, Garret Charlotte, Decavèle Maxence, Fraissé Megan, Herault Antoine, Argaud Laurent, Garçon Pierre, Saccheri Clément, Meunier Juliette, Voriot Guillaume, Cadoz Cyril, Yvin Élise, Laurent Virginie, Calvet Laure, de Montmollin Etienne, Schmidt Julien, Issa Nahema, Leclerc Maxime, Das Vincent, Lemiale Virginie, Mariotte Éric
AP-HP, Hôpital Saint-Louis, Medical ICU, Paris, France.
Intensive Care Unit, CHU de Guadeloupe, Chemin Chauvel, Les Abymes, Guadeloupe.
Crit Care. 2025 Apr 7;29(1):146. doi: 10.1186/s13054-025-05376-w.
Liver abscess (LA) is a rare but potentially serious condition with a high mortality rate. Current epidemiological data of LA patients requiring intensive care unit (ICU) admission are limited.
This multicentre retrospective study included adults admitted to 24 ICUs in France between January 2010 and December 2020. Risk factors for mortality were identified by multivariate analysis. A propensity score was used to adjust for confounders related to the presence of portal vein thrombosis.
335 patients were enrolled. The median age was 66 years [53-73] and 68% were male. Commons comorbidities included diabetes (29.9%) and cancer or haematological disease. Septic shock was the main reason for admission (58%). The median SAPS2 score at ICU admission was 42 [31-53] and the SOFA score was 6 [3-9]. The putative origin of LA was biliary (31%), while 40% were cryptogenic. Most patients (60%) had a solitary LA, involving the right lobe (38.8%), with a median diameter of 67 mm [47-91]. Associated portal vein thrombosis (PVT) was present in 13.4% of cases. Microbiological documentation was obtained in 82% of patients, showing gram-negative bacilli (59.7%), mainly Escherichia coli (19.6%) and Klebsiella spp. (19.1%), and gram-positive cocci (29.6%), mainly Streptococcus spp. (17.1%). Drainage was performed in 62% of cases, 40% within 48 h. The median duration of antibiotic therapy was 35 days [21-42]. During hospitalisation, 62% of patients required vasopressors and 29% required mechanical ventilation. In-ICU mortality was 11.6%. Multivariate analysis showed that organ dysfunction illustrated by SOFA score (HR 3.45 [1.95-6.09], p < 0.001) and PVT (HR 3.14 [1.54-6.39], p = 0.001) were significant risk factors for mortality. Drainage was not associated with improved short-term survival (HR 1.22 [0.65-2.72], p = 0.52). In the population matched for PVT confounders, a higher sofa score was the only factor associated with mortality (HR 3.11 [1.76-5.49] IC95%, p = 0.001).
This multicentre study illustrates the severity of LA in French intensive care units and identifies organ dysfunction (SOFA score) and portal vein thrombosis as major risk factors for mortality. Prospective studies are needed to improve management strategies, as the survival benefit of drainage is unclear.
肝脓肿(LA)是一种罕见但可能严重的疾病,死亡率很高。目前关于需要入住重症监护病房(ICU)的LA患者的流行病学数据有限。
这项多中心回顾性研究纳入了2010年1月至2020年12月期间在法国24个ICU住院的成年人。通过多变量分析确定死亡风险因素。使用倾向评分来调整与门静脉血栓形成相关的混杂因素。
共纳入335例患者。中位年龄为66岁[53 - 73岁],68%为男性。常见合并症包括糖尿病(29.9%)和癌症或血液系统疾病。感染性休克是入院的主要原因(58%)。ICU入院时的中位SAPS2评分为42[31 - 53],SOFA评分为6[3 - 9]。LA的推测起源为胆汁性(31%),而40%为隐源性。大多数患者(60%)有单个LA,累及右叶(38.8%),中位直径为67mm[47 - 91]。13.4%的病例存在相关门静脉血栓形成(PVT)。82%的患者获得了微生物学证据,显示革兰氏阴性杆菌(59.7%),主要是大肠杆菌(19.6%)和克雷伯菌属(19.1%),以及革兰氏阳性球菌(29.6%),主要是链球菌属(17.1%)。62%的病例进行了引流,40%在48小时内进行。抗生素治疗的中位持续时间为35天[21 - 42天]。住院期间,62%的患者需要血管活性药物,29%的患者需要机械通气。ICU内死亡率为11.6%。多变量分析显示,以SOFA评分表示的器官功能障碍(HR 3.45[1.95 - 6.09],p < 0.001)和PVT(HR 3.14[1.54 - 6.39],p = 0.001)是死亡的重要风险因素。引流与短期生存改善无关(HR 1.22[0.65 - 2.72],p = 0.52)。在针对PVT混杂因素进行匹配的人群中,较高的SOFA评分是与死亡相关的唯一因素(HR 3.11[1.76 - 5.49] IC95%,p = 0.001)。
这项多中心研究阐明了法国重症监护病房中LA的严重程度,并确定器官功能障碍(SOFA评分)和门静脉血栓形成是死亡的主要风险因素。由于引流的生存获益尚不清楚,需要进行前瞻性研究以改善管理策略。